Royalty Pharma CFO entity sells 64,399 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Royalty Pharma plc EVP & CFO Terrance P. Coyne, through entity TPC RP EPA1 LLC, reported an open-market sale of 64,399 Class A Ordinary Shares on May 26, 2026 at a weighted average price of $53.9778 per share, executed under a pre-arranged Rule 10b5-1 trading plan. After this sale, that entity held no remaining shares, while other reported direct and indirect accounts continued to hold Class A Ordinary Shares.
Insider Trade Summary 10b5-1
Net Seller: 64,399 shares
Net Sell
5 txns
Insider
Coyne Terrance P.
Role
EVP & CFO
Sold
64,399 shs ($3.48M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Ordinary Shares | 64,399 | $53.9778 | $3.48M |
| holding | Class A Ordinary Shares | -- | -- | -- |
| holding | Class A Ordinary Shares | -- | -- | -- |
| holding | Class A Ordinary Shares | -- | -- | -- |
| holding | Class A Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Class A Ordinary Shares — 0 shares (Indirect, TPC RP EPA1 LLC);
Class A Ordinary Shares — 24,170 shares (Indirect, By Spouse's IRA);
Class A Ordinary Shares — 23,270 shares (Indirect, By IRA);
Class A Ordinary Shares — 1,500 shares (Direct);
Class A Ordinary Shares — 1,450 shares (Indirect, By Spouse)
Footnotes (2)
- F1. All reported transactions were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on February 24, 2026.
- F2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.64 to $54.63 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Shares sold: 64,399 shares
Weighted average sale price: $53.9778 per share
Sale price range: $53.64–$54.63 per share
+5 more
8 metrics
Shares sold
64,399 shares
Open-market sale by TPC RP EPA1 LLC on May 26, 2026
Weighted average sale price
$53.9778 per share
Class A Ordinary Shares sold on May 26, 2026
Sale price range
$53.64–$54.63 per share
Range of prices for multiple sale transactions
Direct holdings after transactions
1,500 shares
Direct Class A Ordinary Shares held following reported transactions
Spouse holdings after transactions
1,450 shares
Indirect ownership via spouse after reported transactions
IRA holdings after transactions
23,270 shares
Indirect ownership via IRA after reported transactions
Spouse's IRA holdings after transactions
24,170 shares
Indirect ownership via spouse's IRA after reported transactions
Entity holdings after sale
0 shares
TPC RP EPA1 LLC Class A Ordinary Shares following sale
Key Terms
Rule 10b5-1 plan, weighted average price, Class A Ordinary Shares, open-market sale, +1 more
5 terms
Rule 10b5-1 plan financial
"All reported transactions were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on February 24, 2026."
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted average price financial
"The reported price in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open-market sale financial
"transaction_action: open-market sale"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
indirect ownership financial
"direct_or_indirect: I, nature_of_ownership: By Spouse"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Royalty Pharma (RPRX) report for Terrance P. Coyne?
Royalty Pharma reported that an entity associated with EVP & CFO Terrance P. Coyne sold 64,399 Class A Ordinary Shares. The sale was executed as an open-market transaction and disclosed in a Form 4 insider trading report filed with regulators.
Were the Royalty Pharma (RPRX) insider sales pre-planned under Rule 10b5-1?
Yes. The filing states all reported transactions were effected under a Rule 10b5-1 trading plan adopted by Terrance P. Coyne on February 24, 2026. Such plans pre-schedule trades, reducing the significance of transaction timing as a signal of insider sentiment.
How is the sale price range for the Royalty Pharma (RPRX) insider transaction described?
The Form 4 lists a weighted average sale price of $53.9778 per share. It explains that the 64,399 shares were sold in multiple trades at prices ranging between $53.64 and $54.63, and detailed breakdowns are available upon written request to the holder.
AI-generated analysis. How Rhea-AI works. Not financial advice.
